Cor Vasa 2024, 66(4):411-416 | DOI: 10.33678/cor.2024.027

Baseline intervals in electrocardiogram for risk stratification in Brugada syndrome: A 10-year prospective study

Vanda Devesa Netoa, b, Joana Correiaa, António Costaa, Luís Santosa
a Cardiology Department, Tondela-Viseu Hospital Centre, Viseu, Portugal
b Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal

Background: Risk stratification in Brugada syndrome (BrS) remains challenging. The aim of this study was to evaluate the baseline intervals in resting ECG of a cohort of Portuguese patients with first-degree relatives diagnosed with BrS and to identify ECG parameters associated with cardiac events (CE) over a 10-year period.

Methods: Prospective study assessing 107 Portuguese patients with first-degree relatives diagnosed with BrS and followed over a decade to detect CE. Subgroups included spontaneous type 1 (SB), inducible type 1 (IB), and normal ECG. CE were a composite endpoint comprising of sudden cardiac death (SCD), implantable cardioverter-defibrillator (ICD) implantation and appropriate ICD shocks.

Results: 15% patients with SB and 10% patients with IB, mean age was 29.9±16 years; 51% were male. SB and IB patients exhibited significantly higher PR intervals than those with normal ECG (p <0.01, p = 0.02, respectively). There were no differences in PR interval between SB and IB (p = 0.93). CE occurred in 41.5% of SB and in 18.2% of IB patients. No CE in patients with normal ECG and normal flecainide provocative test. PR interval was an independent predictor of earlier CE (HR 1.06 CI 95% [1.02-1.10]; p <0.01), adjusted to familiar SCD and positive genetic test. Mean time for a CE was significantly shorter in patients with PR >200 ms and the optimal cutoff value for predicting CE was 180 ms.

Conclusion: The PR interval is a significant parameter in basal ECG associated with CE in BrS. Considering the PR interval in the design of clinical algorithms is recommended for accurate individual risk assessment.

Keywords: Brugada syndrome, Electrocardiography, Risk stratification

Received: February 14, 2024; Revised: March 14, 2024; Accepted: March 19, 2024; Prepublished online: June 2, 2012; Published: September 9, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neto VD, Correia J, Costa A, Santos L. Baseline intervals in electrocardiogram for risk stratification in Brugada syndrome: A 10-year prospective study. Cor Vasa. 2024;66(4):411-416. doi: 10.33678/cor.2024.027.
Download citation

References

  1. Zeppenfeld J, Asano T, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126. Go to original source... Go to PubMed...
  2. Honarbakhsh S, Providência R, Lambiase PD. Risk Stratification in Brugada Syndrome: Current Status and Emerging Approaches. Arrhythm Electrophysiol Rev 2018;7:79-83. Go to original source... Go to PubMed...
  3. Makiyama T, Akao M, Tsuji K, et al. High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol 2005;46:2100-2106. Go to original source... Go to PubMed...
  4. Pranata R, Yonas E, Chintya V, et al. Association between PR Interval, First-degree atrioventricular block and major arrhythmic events in patients with Brugada syndrome - Systematic review and meta-analysis. J Arrhythm 2019;35:584-590. Go to original source... Go to PubMed...
  5. Honarbakhsh S, Providência R, Garcia-Hernandez J, et al. A Primary Prevention Clinical Risk Score Model for Patients with Brugada Syndrome (BRUGADA-RISK). JACC: Clin Electrophysiol 2021;7:210-222. Go to original source... Go to PubMed...
  6. Migliore F, Testolina M, Zorzi A, et al. First-degree atrioventricular block on basal electrocardiogram predicts future arrhythmic events in patients with Brugada syndrome: a long-term follow-up study from the Veneto region of Northeastern Italy. Europace 2019;21:322-331. Go to original source... Go to PubMed...
  7. Chung FP. Risk stratification beyond electrocardiographic manifestation in Brugada syndrome: The important parameter of PR interval. J Arrhythm 2019;35:591-592. Go to original source... Go to PubMed...
  8. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 2012;59:37-45. Go to original source... Go to PubMed...
  9. Milman A, Andorin A, Gourraud JB, et al. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS). Heart Rhythm 2018;15:716-724. Go to original source... Go to PubMed...
  10. Morita H, Watanabe A, Morimoto Y, et al. Distribution and prognostic significance of fragmented QRS in patients with Brugada syndrome. Circ Arrhythm Electrophysiol 2017;10:e004765. Go to original source... Go to PubMed...
  11. Junttila MJ, Brugada P, Hong K, et al. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol 2008;19:380-383. Go to original source... Go to PubMed...
  12. Ohkubo K, Watanabe I, Okumura Y, et al. Prolonged QRS duration in lead V2 and risk of life-threatening ventricular arrhythmia in patients with Brugada syndrome. Int Heart J 2011;52:98-102. Go to original source... Go to PubMed...
  13. Huang Z, Patel C, Li W, et al. Role of signal averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm 2009;6:1156-1162. Go to original source... Go to PubMed...
  14. Maury P, Sacher F, Gourraud JB, et al. Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome. Heart Rhythm 2015;12:2469-2476. Go to original source... Go to PubMed...
  15. Babai Bigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm 2007;4:1009-1012. Go to original source... Go to PubMed...
  16. Ragab AAY, Houck CA, van der Does LJME, et al. Usefulness of the R-wave sign as a predictor for ventricular tachyarrhythmia in patients with Brugada syndrome. Am J Cardiol 2017;120:428-434. Go to original source... Go to PubMed...
  17. Calò L, Giustetto C, Martino A, et al. A new electrocardiographic marker of sudden death in Brugada syndrome: the S-wave in lead I. J Am Coll Cardiol 2016;67:1427-1440. Go to original source... Go to PubMed...
  18. Giustetto C, Nangeroni G, Cerrato N, et al. Ventricular conduction delay as marker of risk in Brugada syndrome. Results from the analysis of clinical and electrocardiographic features of a large cohort of patients. Int J Cardiol 2020;302:171-177. Go to original source... Go to PubMed...
  19. Fish JM, Antzelevitch C. Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome. J Cardiovasc Electrophysiol 2008;19:301-308. Go to original source... Go to PubMed...
  20. Gaita F, Cerrato N, Giustetto C, et al. Asymptomatic patients with Brugada ECG pattern: long-term prognosis from a large prospective study. Circulation 2023;148:1543-1555. Go to original source... Go to PubMed...
  21. Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation 2010;121:635-643. Go to original source... Go to PubMed...
  22. El-Battrawy I, Pilsitz P, Liebe V, et al. Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up. Clin Cardiol 2019;42:958-965. Go to original source... Go to PubMed...
  23. Sieira J, Conte G, Ciconte G, et al. Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience. Circ Arrhythm Electrophysiol 2015;8:777-784. Go to original source... Go to PubMed...
  24. Satryan A, Kojuri J, Ben-Haim Y, et al. Sex-Related Differences in Cardiac Channelopathies. Circulation 2020;143:739-752. Go to original source... Go to PubMed...
  25. Benito B, Sarkozy A, Mont L, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008;52:1567-1573. Go to original source... Go to PubMed...
  26. Sacher F, Meregalli P, Veltmann C, et al. Are women with severely symptomatic brugada syndrome different from men? J Cardiovasc Electrophysiol 2008;19:1181-1185. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.